61 filings
Page 2 of 4
8-K
2iuvi2ndiplgf6cj6umw
12 Apr 23
Mirum Pharmaceuticals Announces Preliminary Unaudited First Quarter 2023 Financial Results
6:54am
8-K
1cvv4s21v1
6 Apr 23
Departure of Directors or Certain Officers
7:31am
8-K
np8enaplqm13gi
10 Mar 23
Other Events
5:29pm
8-K
vau5jyl9bwl9c 36dh2
8 Mar 23
Results of Operations and Financial Condition
4:03pm
8-K
lciu1jih4zff zx
9 Jan 23
Mirum Pharmaceuticals Announces Preliminary Unaudited LIVMARLI 2022 Net Revenue and Provides Corporate Updates
8:46am
8-K
aeh1ampuz9 s5c
19 Dec 22
Departure of Directors or Certain Officers
8:30am
8-K
h9opw5ptou
13 Dec 22
Other Events
4:30pm
8-K
9x3p146qtgpkv
29 Nov 22
Other Events
8:01am
8-K
t80k6pm1 wn0ju
9 Nov 22
Results of Operations and Financial Condition
7:30am
8-K
uhgtyb8fvyap5fs6
24 Oct 22
Regulation FD Disclosure
8:46am
8-K
glq5di
2 Sep 22
Departure of Directors or Certain Officers
4:30pm
8-K
2sl9 2knqkvi7zv5lm6
10 Aug 22
Other Events
12:00am
8-K
o6blxdf57pbib4cwg
4 Aug 22
Results of Operations and Financial Condition
4:03pm
8-K
0mv77sc43v6em8z2fn8z
6 Jun 22
Mirum Pharmaceuticals Appoints Saira Ramasastry to Board of Directors
8:32am
8-K
vj2wr6
23 May 22
Other Events
9:01am
8-K
ozpyfsi
5 May 22
Results of Operations and Financial Condition
8:05am
8-K
9e3m147b0kg3
9 Mar 22
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
4:05pm
8-K
s3o8n4
11 Jan 22
Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones
9:00am
8-K
hl76ldxmf
22 Dec 21
Completion of Acquisition or Disposition of Assets
4:05pm
8-K
fu7tobdz3
19 Nov 21
Entry into a Material Definitive Agreement
6:08am